What's new in lipid management? - Wikidata - awgldk - TriplyDB

What's new in lipid management?

What's new in lipid management?

http://www.wikidata.org/entity/Q35549738

about

What's new in lipid management?

http://www.wikidata.org/entity/Q35549738

description

2003 nî lūn-bûn

@nan

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

What's new in lipid management?

@ast

What's new in lipid management?

@en

type

label

What's new in lipid management?

@ast

What's new in lipid management?

@en

prefLabel

What's new in lipid management?

@ast

What's new in lipid management?

@en

P1433

Q35549738-F91E013E-301F-40D0-A9CF-33D35ED68587

P1476

Q35549738-6AE67083-578D-4DE1-AC1B-21CA6EA4F0DB

P2093

Q35549738-81B8DF74-A44E-44AE-B136-388AEAB44380

P2860

Q35549738-0548BCEA-DB50-4713-A1D0-EBCE56EC9825

Q35549738-20856720-FBDE-4FDA-BEFD-1D0E7E31FC9C

Q35549738-22337A0B-B7E7-44DF-96E0-890DE2FB5073

Q35549738-2D61E26A-7602-4953-997E-2901D91E3A7F

Q35549738-3C69DCA2-DADC-4AF5-98ED-80194973DE7D

Q35549738-5D65FAEA-5F75-4E94-BC06-9EDB8C83AA30

Q35549738-71145056-1596-4011-A2DB-C3473CB311E6

Q35549738-84A0A611-53F3-46C8-9350-A05B77926754

Q35549738-8B48835E-3068-4722-955F-B46FB0BB053B

Q35549738-92966F7A-8D6A-4B15-941B-74A944928299

P304

Q35549738-5F84C8A1-C1CB-4BD3-8913-59FC4FD5329C

P31

Q35549738-891D271E-2A16-4390-B28C-5FDC466DA5DA

P356

Q35549738-1C82BC63-1B4D-4CF0-9F58-1EE5EC6D8C25

P407

Q35549738-3E3F6EC8-D094-4152-A20A-4E09E72D6E03

P433

Q35549738-C52A7584-5C07-4E92-9B2E-CB550442C513

P478

Q35549738-C25701FE-E5D0-4AB8-B614-AA628718B816

P577

Q35549738-0787930F-33EC-4309-A8AA-83F81A427382

P698

Q35549738-02E8FF85-23C4-4BEE-B4D1-04DBE8DACE81

P356

PHCO.23.11.34S.32711

P1433

Pharmacotherapy

P1476

What's new in lipid management?

@en

P2093

Paul D Thompson

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Statin therapy and reductions in low-density lipoprotein cholesterol: initial clinical data on the potent new statin Rosuvastatin.

High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial.

Management of hypercholesterolemia.

Current, new and future treatments in dyslipidaemia and atherosclerosis.

Choosing the right lipid-regulating agent. A guide to selection.

P304

34S-40S

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.23.11.34S.32711

http://www.w3.org/2001/XMLSchema#string

P407

P433

9 Pt 2

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14524637

http://www.w3.org/2001/XMLSchema#string